NUHS Institutions will NEVER ask you to transfer money or disclose bank details over a call.
If in doubt, call the 24/7 ScamShield helpline at 1799, or visit the ScamShield website at www.scamshield.gov.sg.
Dr Mamta graduated from Kings College London. Thereafter she completed her early medical and advanced general medicine and respiratory medicine training in and around London and Cambridge. She spent a year working in New Zealand. She also completed a PhD in lung cancer screening from University College London, where she also gained expertise in endobronchial ultrasound and lung cancer diagnosis and staging. She attained her specialist accreditation in respiratory medicine in Singapore. She is an clinical senior lecturer in NUS's clinical faculty scheme and regularly teaches undergraduate student and postgraduate junior doctors. Her research interests include early detection of lung cancer and lung cancer screening (including inequalities in uptake, optimal selection criteria, mangement of lung nodules and other incidental findings).
1. Ruparel M. Lung cancer screening in advanced chronic obstructive pulmonary disease: helpful or harmful? Thorax. 2023 Mar 21:thorax-2022-219778. doi: 10.1136/thorax-2022-219778.
2. Ruparel M. Should we retain smaller growing nodules in lung cancer screening programmes for surveillance? Thorax. 2023 May;78(5):427-428. doi: 10.1136/thorax-2022-219838
3. Hall H*, Ruparel M*, Quaife SL, Dickson JL, Horst C, Tisi S, Batty J, Woznitza N, Ahmed A, Burke S, Shaw P, Soo MJ, Taylor M, Nair A, Navani N, Bhowmik, Baldwin DR, Duffy SW, Nair A*, Devaraj A*, Janes SM*. The role of computer-assisted radiographer reporting in lung cancer screening programmes. Eur Radiol. 2022 Oct;32(10):6891-6899.
4. Tammemägi MC, Ruparel M, Tremblay A, … Janes SM, Fong K, Lam S. USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort study. Lancet Oncol. 2022 Jan;23(1):138-148.
5. Horst C, Dickson JL, Tisi S, Ruparel M, Nair A, Devaraj A, Janes SM. Delivering low-dose CT screening for lung cancer: a pragmatic approach. Thorax. 2020 Oct;75(10):831-832. doi: 10.1136/thoraxjnl-2020-215131.
6. Ruparel M, Quaife SL, Dickson JL, Horst C, Tisi S, Hall H, Taylor M, Ahmed A, Shaw P, Burke S, Soo MJ, Nair A, Devaraj A, Sennett K, Duffy SW, Navani N, Bhowmik A, Baldwin DR, Janes SM. Lung Screen Uptake Trial: results from a single lung cancer screening round. Thorax. 2020 Oct;75(10):831-832.
7. Ruparel M, Quaife SL, Dickson JL, Horst C, Tisi S, Hall H, Taylor M, Ahmed A, Shaw P, Burke S, Soo MJ, Nair A, Devaraj A, Sennett K, Hurst JR, Duffy SW, Navani N, A Bhowmik, Baldwin DR, A, Janes SM. Prevalence, symptom burden and under-diagnosis of Chronic Obstructive Pulmonary Disease in a lung cancer screening cohort. Ann Am Thorac Soc. 2020 Mar 13.
8. Quaife SL, Ruparel M, Dickson JL, Beeken RJ, McEwen A, Bldwin DR, Bhowmik A, Navani N, Sennett K, Duffy S, Waller J, Janes SM. Lung Screen Uptake Trial (LSUT): Randomised controlled trial testing targeted invitation materials. Am J Respir Crit Care Med. 2019 Dec 11.
9. Ruparel M, Quaife SL, Dickson JL, Horst C, Burke S, Taylor M, Ahmed A, Shaw P, Soo MJ, Nair A, Devaraj A, O'Dowd EL, Bhowmik A, Navani N, Sennett K, Duffy SW, Baldwin DR, Sofat R, Patel RS, Hingorani A, Janes SM. Evaluation of cardiovascular risk in a lung cancer screening cohort. Thorax. 2019 Dec;74(12):1140-1146.
10. Ruparel M, Quaife SL, Ghimire B, Dickson JL, Bhowmik A, Navani N, Baldwin DR, Duffy S, Waller J, Janes SM. Impact of a Lung Cancer Screening Information Film on Informed Decision-Making: A Randomized Trial. Ann Am Thorac Soc. 2019 Jun;16(6):744-751.